“No Association Between Sleep Apnoea And Macular Telangiectasia Type 2 And Its Markers Of Severity And Progression: A Case-Control Study And Retrospective Cohort Study.”. Clin Exp Ophthalmol 47 (1). Clin Exp Ophthalmol: 63-68. doi:10.1111/ceo.13363.
. 2019. “Medical Characteristics Of Patients With Macular Telangiectasia Type 2 (Mactel Type 2) Mactel Project Report No. 3.”. Ophthalmic Epidemiol 20 (2). Ophthalmic Epidemiol: 109-13. doi:10.3109/09286586.2013.766757.
. 2013. “"en Face" Oct Imaging Of The Is/os Junction Line In Type 2 Idiopathic Macular Telangiectasia.”. Invest Ophthalmol Vis Sci 53 (10). Invest Ophthalmol Vis Sci: 6145-52. doi:10.1167/iovs.12-10580.
. 2012. “Identification Of A Potential Susceptibility Locus For Macular Telangiectasia Type 2.”. Plos One 7 (8). Plos One: e24268. doi:10.1371/journal.pone.0024268.
. 2012. “The Is/os Junction Layer In The Natural History Of Type 2 Idiopathic Macular Telangiectasia.”. Invest Ophthalmol Vis Sci 53 (12). Invest Ophthalmol Vis Sci: 7889-95. doi:10.1167/iovs.12-10765.
. 2012. “The National Eye Institute Visual Function Questionnaire In The Macular Telangiectasia (Mactel) Project.”. Invest Ophthalmol Vis Sci 49 (10). Invest Ophthalmol Vis Sci: 4340-6. doi:10.1167/iovs.08-1749.
. 2008.